
Getting a GRiP on chemoresistance: A review of GRP78 as a therapeutic target in cancer
Innate or acquired resistance to current standard-of-care therapies is a major hindrance to successful chemotherapeutic…
Innate or acquired resistance to current standard-of-care therapies is a major hindrance to successful chemotherapeutic…